Posted: 13 February 2025
The Company
Our client is an early-stage biotechnology company developing first-in-class small molecule inhibitors to treat metabolic diseases. With funding and support from venture capital, and an expert core team, they are dedicated to advancing development of their therapeutic candidates and delivering effective treatments for diseases associated with obesity and type-2 diabetes.
The Opportunity
Our client is seeking an experienced professional who can drive the development and execution of a strategy for their preclinical research program. Working closely with the CSO and founder, you will:
- Form a preclinical development strategy to establish a lead series of neurofibrosis inhibitors, including identification of key project milestones and regulatory considerations for advancement to clinical testing
- Manage project deliverables, including data sharing between CROs and collaborators, according to established timelines, milestones, available resources, and budget
- Design experiments to identify biomarkers of toxicology and efficacy and manage their validation and use by CROs to assess potential drug candidates
- Interpret data generated by research projects to prioritize potential inhibition targets based on criteria including druggability, toxicity, safety, and mechanism of action
- Communicate research updates, risk escalations, important changes to projects, and important findings to other members of the scientific team and the board
The Requirements
- High level of experience in preclinical development pathways for small molecule drugs.
- PhD or equivalent experience in pharmacology or related discipline.
- Strong understanding of metabolic disorders and the biology underpinning obesity and type-2 diabetes.
- Ability to demonstrate very strong organisational, planning, and problem-solving skills.
- Strong verbal and written communication skills, particularly around scientific concepts and research data.
- Track record of initiative and innovative thinking, especially while working as part of a small, agile team.
The Offer
The successful candidate will enhance their expertise in preclinical drug development through collaboration and interaction with the core team, expert advisors, and the board. The total remuneration package and position title offered will reflect individual experience and those who meet the requirements described are encouraged to apply. Please email any questions you may have to careers@mexec.com or call 1300 063 932 to arrange a time for a confidential discussion with Mark Thomas or Marilyn Jones.
To apply, please visit www.mexec.com and click Apply Now to submit your current CV and cover letter.
